切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - guanylyl cyclase - PAK - Nrf2 - 5-HT7 Receptors

11件产品中的 1-10

页面
每页
清除全部
  1. A 350619 hydrochloride
    B5336 A 350619 hydrochloride
    Target: guanylyl cyclase
    Summary: 可溶性鸟苷酸环化酶(sGC)激活剂
      ≥21.25 mg/mL
      ≥25.7 mg/mL
  2. Omaveloxolone (RTA-408)
    B3576 Omaveloxolone (RTA-408)
    Target: Nrf2
    Summary: Nrf2激活剂
      ≥55.5 mg/mL
      insoluble in H2O
  3. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  4. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  5. IPA-3
    B2169 IPA-3
     1 Citation
    Target: PAK
    Summary: 非竞争性Pak1抑制剂
      ≥16.1 mg/mL
      insoluble in H2O
  6. FRAX597
    B1162 FRAX597
     1 Citation
    Target: PAK
    Summary: ATP竞争性的PAK抑制剂
      ≥27.9 mg/mL
      insoluble in H2O
  7. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  8. PF-3758309
    A3716 PF-3758309
     1 Citation
    Target: PAK
    Summary: PAK4抑制剂
      ≥24.53 mg/mL
      insoluble in H2O
  9. Curcumin
    A3335 Curcumin
     1 Citation
    中文名: 姜黄素
    Target: Histone Deacetylases (HDACs)|Nrf2|Histone Acetyltransferases (HATs)|Tyrosinases
    Summary: Tyrosinase(酪氨酸酶)抑制剂
      ≥36.8 mg/mL
      insoluble in H2O
  10. Cinaciguat
    A3314 Cinaciguat
    Target: guanylyl cyclase
    Summary: 可溶性鸟苷酸环化酶(sGC)激活剂
      Soluble in DMSO

11件产品中的 1-10

页面
每页